Deepika A. Lakhani serves as the Vice President of Regulatory & Quality, at PAVmed Inc. She was appointed to the position in 2022.  Prior to her current role, Deepika was at AstraZeneca Pharmaceuticals in Global Regulatory Affairs and has spent nearly 11 years at the FDA where she started as a reviewer in Center for Drugs Evaluation and Research (CDER) and subsequently served in multiple positions in CDER and Center for Devices and Radiological Health (CDRH) involved with the review of medical devices, drugs, biologics, and combination products. Deepika considers regulatory affairs to be a creative process that enables innovation. She has multiple peer-reviewed publications, received many awards for excellence and leadership while at the FDA and still serves on the FDA Alumni Association. She holds a Ph.D. in Pharmaceutics from the Aerosol Research Group, Virginia Commonwealth University.